Medical Properties Trust

Business

Mineralys Therapeutics Submits New Drug Application for Hypertension Treatment Lorundrostat, Backed by Strong Clinical Data

Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.

Jan 30, 2026

Business

Bank of America Bullish on Apellis, Upgrades to 'Buy' on Strong Drug Launch and Kidney Disease Prospects

Bank of America has upgraded Apellis Pharmaceuticals (APLS) to 'Buy,' citing robust early adoption of its drug Empaveli and significant undervaluation of its potential in treating rare kidney diseases, despite a more cautious outlook from Wells Fargo.

Jan 30, 2026

Business

NextPower Soars on Strong Earnings, Lands Major Saudi Deal as Analyst Target Jumps

NextPower Inc. sees its price target raised by TD Cowen following a robust third-quarter earnings beat and a landmark joint venture in Saudi Arabia, signaling growing confidence in the solar technology firm's trajectory.

Jan 30, 2026

Business

Microsoft's AI Spending Spree Sends Shockwaves Through Markets, Dragging Tech Sector Into Bear Territory

A sharp sell-off in Microsoft shares following its earnings report has ignited fresh fears over the profitability of massive AI investments, pulling major indexes lower and pushing the software sector into a bear market.

Jan 30, 2026

Business

Gallagher Posts Strong Q4 Growth, Eyes M&A Expansion Amid Stable Casualty Market

Arthur J. Gallagher & Co. reported robust revenue growth exceeding 30% for the fourth quarter of 2025, driven by a healthy mergers and acquisitions pipeline and resilient performance in key sectors. Leadership expressed confidence in navigating a softening property insurance market while maintaining stable casualty pricing and talent retention.

Jan 30, 2026

Business

ResMed Posts Strong Q2 Growth on New Product Momentum and GLP-1 Therapy Tailwinds

ResMed Inc. reports an 11% revenue surge for its second fiscal quarter, driven by robust mask sales and strategic acquisitions, while navigating competitive pressures and capitalizing on emerging healthcare trends.

Jan 30, 2026

Business

Credit Acceptance Navigates Market Headwinds with Tech Focus and Steady Earnings Growth

Despite facing a dip in loan performance and market share, Credit Acceptance Corp (CACC) posted growth in adjusted earnings per share for Q4 2025, highlighting strategic investments in dealer technology and a disciplined, long-term financial approach.

Jan 30, 2026

Business

KeyCorp Posts Strong Q4 Earnings and Announces Capital Moves, But Core Bull Thesis Remains Unchanged

KeyCorp's latest quarterly results beat expectations, fueled by higher net interest income and a return to full-year profitability. The regional bank also completed a $200 million share buyback and issued $750 million in new debt, while refreshing its board. Analysts suggest these moves fine-tune the bank's strategy rather than radically alter its investment narrative.

Jan 30, 2026

Business

SAP Shifts Healthcare Strategy, Appoints New North America Chief Amid Market Scrutiny

SAP discontinues its legacy IS-H healthcare software in the DACH region, impacting dozens of hospitals, while appointing David Robinson to lead its crucial North American operations. The moves signal a strategic pivot as the enterprise software giant navigates a complex market landscape.

Jan 30, 2026

Business

Beyond the Penny Stock Label: Three Asian Equities Showing Financial Resilience

In a volatile market, certain low-priced Asian stocks are drawing attention not just for their valuation, but for underlying financial strength. We examine three such companies—from healthcare in New Zealand to property services in Greater China—that defy the typical 'penny stock' stereotype with solid fundamentals.

Jan 30, 2026

Business

Analysis: Asian Equities Trading at Steep Discounts, With Some Stocks Undervalued by Over 25%

Amidst global market turbulence, a new screen reveals a significant number of Asian stocks are trading below their intrinsic value, with discounts as high as 26.4%. We examine three standout companies from South Korea, Thailand, and Japan that appear poised for a potential re-rating.

Jan 30, 2026

Business

Insider Confidence: Asian Growth Stocks Where Leadership Has Skin in the Game

Amidst market volatility, a select group of Asian companies with significant insider ownership are drawing investor attention, signaling strong internal belief in their long-term growth trajectories.

Jan 30, 2026

Business

Textron's Defense Surge: Record Revenue and Ukraine Vehicle Contract Fuel Growth, But Questions on Sustainability Linger

Textron secures a major $163.4 million military contract while posting record annual revenue, driven by strength in Aviation and Bell. As its stock shows robust long-term gains, analysts debate whether this momentum is built to last.

Jan 30, 2026

Business

P&G Bolsters Health Portfolio with Acquisition of Digestive Wellness Brand Wonderbelly

Consumer goods giant Procter & Gamble has agreed to acquire Wonderbelly, a fast-growing brand in the 'free-from' digestive health space, signaling a deeper push into the lucrative wellness category and a bid to attract younger, label-conscious consumers.

Jan 30, 2026

Business

Beyond the Headlines: Unearthing Small-Cap Opportunities in Asia's Volatile 2026 Markets

Amidst a complex backdrop of economic crosscurrents and geopolitical tensions, a select group of small-cap companies across Asia are demonstrating remarkable resilience and growth potential. We analyze three standout names from Singapore and China that are navigating the volatility with strong fundamentals.

Jan 30, 2026

Business

Medicare Advantage Funding Freeze Puts Clover Health's Profitability in the Spotlight

Proposed flat payment rates for 2027 by CMS intensify margin pressures on Medicare Advantage insurers like Clover Health, raising investor concerns about cost management and growth prospects in a tightening regulatory landscape.

Jan 30, 2026

Business

Mastercard Caps Off 'Very Strong' 2025, Eyes Growth in Services and New Tech for 2026

Mastercard reported robust Q4 and full-year 2025 results, driven by double-digit revenue growth and surging value-added services. Executives expressed confidence for 2026, highlighting strategic wins, investments in digital assets like stablecoins, and a focus on 'agentic commerce,' even as they plan a restructuring affecting 4% of staff.

Jan 30, 2026

Business

Kirby Caps Record 2025 with Strong Momentum, Eyes Steady Growth Amid Market Headwinds

Kirby Corporation (NYSE: KEX) reported record annual earnings for 2025, fueled by robust free cash flow and strategic capital returns. While Q4 faced seasonal pressures, management highlighted a late-quarter rebound in inland marine and surging demand in power generation, setting the stage for what they project as a year of steady financial performance in 2026.

Jan 30, 2026

Business

Lazard Posts Record Advisory Revenue in 2025, Citing Strategic Gains and Asset Management Turnaround

Lazard Ltd. reported strong fourth-quarter and full-year 2025 results, driven by record financial advisory fees and a rebound in assets under management. Executives framed the performance as validation of the firm's long-term 'Lazard 2030' strategy, highlighting talent investments and a robust pipeline for future growth.

Jan 30, 2026

Business

South Korea Proposes Sweeping Crypto Overshaul, Aiming to Align Digital Asset Rules with Traditional Banking

South Korean regulators are forming a task force to propose stricter anti-money laundering rules for cryptocurrency transactions by 2026, potentially removing minimum thresholds for identity disclosure to mirror traditional finance oversight.

Jan 30, 2026